(Q27027545)

5

object named as

Thomas W. Wakefield

1 reference

April L. Rodriguez

1

1 reference

Brandon M. Wojcik

2

1 reference

Shirley K. Wrobleski

3

1 reference

Daniel D. Myers

4

1 reference

Jose A. Diaz

6

1 reference

language of work or name

1 reference

May 2012

1 reference

Journal of Thrombosis and Thrombolysis

published in

1 reference

volume

33

1 reference

issue

4

1 reference

page(s)

371-82

1 reference

Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Use of statins and the subsequent development of deep vein thrombosis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Incidence and cost burden of post-thrombotic syndrome

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levels

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

A randomized trial of rosuvastatin in the prevention of venous thromboembolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

The investigation and surgery of the post-thrombotic syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

ABC of vascular diseases. Deep venous insufficiency and occlusion

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop

28 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

Preprocedural statin administration can reduce thrombotic reaction after stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

Monocyte recruitment in venous thrombus resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

Interleukin-8 administration enhances venous thrombosis resolution in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

Statins decrease the occurrence of venous thromboembolism in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0687-9

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338886

Recurrent venous thrombosis and markers of inflammation

28 November 2018

1 reference

12 December 2020

Inflammatory response in the acute phase of deep vein thrombosis

1 reference

12 December 2020

The post-thrombotic syndrome

1 reference

12 December 2020

Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis

1 reference

12 December 2020

P-selectin and TNF inhibition reduce venous thrombosis inflammation

1 reference

12 December 2020

Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism

1 reference

12 December 2020

Interleukin-6 and interleukin-6 promoter polymorphism (−174) G>C in patients with spontaneous venous thromboembolism

1 reference

12 December 2020

Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation

1 reference

12 December 2020

Unraveling pleiotropic effects of statins: bit by bit, a slow case with perspective

1 reference

12 December 2020

HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis

1 reference

12 December 2020

Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study

1 reference

12 December 2020

Interleukin-6: a potential target for post-thrombotic syndrome

1 reference

12 December 2020

Non lipid, dose-dependent effects of pravastatin treatment on hemostatic system and inflammatory response

1 reference

12 December 2020

10.1007/S11239-012-0687-9

Identifiers

DOI

1 reference

Dimensions Publication ID

1003705177

0 references

1 reference

1 reference

PubMed publication ID

22278047

1 reference